Daniel E. Adkins

This paper identifies 58 genome-wide significant loci for major anxiety disorders using a large meta-analysis and highlights GABAergic signaling as a potential mechanism.

This study identifies 52 genetic variants associated with adolescent-onset depression through a large GWAS, revealing age-specific mechanisms and potential drug targets.

This study conducts a genome-wide association meta-analysis of childhood aggression across multiple raters, instruments, and ages, identifying genetic correlations with various traits but no genome-wide significant SNPs.

This paper conducts a genome-wide association study of suicide death and shows polygenic scores predict suicide case-control status and related psychiatric traits.

This study finds that subthreshold psychosis symptoms in a population-based cohort are associated with genetic risks for schizophrenia, ADHD, autism, and neuroticism, with notable sex differences.

The paper compares genome-wide data from opioid use and dependence cases to identify genetic associations and differences between exposure and dependence.

The paper constructs a polygenic risk atlas for 33 traits in emerging adults and finds genetic risks for schizophrenia, neuroticism, and depression predict various phenotypes.

The paper uses GWAS data to identify polygenic risk scores for drug metabolism pathways, finding that the GO:17144 pathway is significantly predictive of recurrent depressive disorder.

This paper investigates how global polygenic risk scores, sex, and their interaction predict schizophrenia risk using a classification model, finding sex and polygenic risk are the strongest predictors.